DCM
SGEN

Deuterium Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Deuterium Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$212K – 74
2023
Q3 		$212K Buy
+1,000
New +$200K 0.51% 43
2022
Q2 		– Sell
-15,750
Closed -$2.27M – 90
2022
Q1 		$2.27M Sell
15,750
-2,250
-13% -$304K 2.92% 9
2021
Q4 		$2.78M Buy
+18,000
New +$3.01M 4.12% 6

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Deuterium Capital Management's SGEN Position: Q4 2023 in Review

Deuterium Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,000 shares — an estimated $212K sold.

Deuterium Capital Management first reported a position in SGEN in Q4 2021 and held it in 3 quarters. The position peaked at $2.78M in Q4 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Deuterium Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 1,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $212K.
  • Deuterium Capital Management first reported a position in Seagen Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Deuterium Capital Management's Seagen Inc. Common Stock position peaked at $2.78M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Deuterium Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.